Gaps in information, support among women who gain weight during breast cancer treatment
the ONA take:
There may be gaps in information and support provision after diagnosis in the areas of weight management, nutrition-related side effects of chemotherapy, and healthy living among women undergoing chemotherapy for breast cancer, a study published in the journal Supportive Care in Cancer had shown.
For the study, researchers sought to explore the experiences, dietary information, and support needs of women who gain weight during chemotherapy treatment for breast cancer as overweight and obesity are associated with reduced self-esteem, other co-morbidities, and an increased risk of cancer recurrence.
Researchers observed three key themes when interviewing 17 women who gained weight: 1) undesirable impacts of cancer treatment on diet and physical activity, 2) surprise and concern related to weight and diet changes, and 3) insufficient dietary education and support.
The authors conclude that "models of dietetic practice and the provision of tailored dietary information should be explored."
There may be gaps in information and support provision after diagnosis for breast cancer.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|